ClinVar Genomic variation as it relates to human health
NM_000372.5(TYR):c.1205G>A (p.Arg402Gln)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Pathogenic(1); Likely pathogenic(1); Uncertain significance(6); Benign(1); Likely benign(2)
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000372.5(TYR):c.1205G>A (p.Arg402Gln)
Variation ID: 3779 Accession: VCV000003779.50
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 11q14.3 11: 89284793 (GRCh38) [ NCBI UCSC ] 11: 89017961 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 1, 2013 Oct 20, 2024 Jul 1, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000372.5:c.1205G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000363.1:p.Arg402Gln missense NC_000011.10:g.89284793G>A NC_000011.9:g.89017961G>A NG_008748.1:g.111922G>A P14679:p.Arg402Gln - Protein change
- R402Q
- Other names
-
TYR, ARG402GLN (rs1126809)
- Canonical SPDI
- NC_000011.10:89284792:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.08127 (A)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
1000 Genomes Project 0.08127
1000 Genomes Project 30x 0.08198
Trans-Omics for Precision Medicine (TOPMed) 0.17249
The Genome Aggregation Database (gnomAD), exomes 0.17644
Exome Aggregation Consortium (ExAC) 0.17697
The Genome Aggregation Database (gnomAD) 0.18094
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
TYR | - | - |
GRCh38 GRCh37 |
689 | 710 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Likely pathogenic (3) |
criteria provided, single submitter
|
- | RCV000003978.15 | |
Pathogenic (1) |
no assertion criteria provided
|
Jun 1, 2013 | RCV000003979.8 | |
risk factor (1) |
no assertion criteria provided
|
Jun 1, 2013 | RCV000003980.8 | |
association (1) |
no assertion criteria provided
|
Jun 1, 2013 | RCV000003981.8 | |
association (1) |
no assertion criteria provided
|
Jun 1, 2013 | RCV000003982.8 | |
Conflicting interpretations of pathogenicity; other (5) |
criteria provided, conflicting classifications
|
Jul 1, 2024 | RCV000085910.34 | |
Conflicting interpretations of pathogenicity (2) |
criteria provided, conflicting classifications
|
Feb 8, 2023 | RCV000254054.12 | |
Conflicting interpretations of pathogenicity (4) |
criteria provided, conflicting classifications
|
Jul 22, 2021 | RCV000500466.16 | |
no classifications from unflagged records (1) |
no classifications from unflagged records
|
Jan 30, 2021 | RCV000626673.5 | |
other (1) |
no assertion criteria provided
|
Sep 10, 2018 | RCV000721172.3 | |
Likely benign (1) |
no assertion criteria provided
|
- | RCV001269379.3 | |
Uncertain significance (1) |
criteria provided, single submitter
|
Oct 31, 2019 | RCV003985252.2 | |
Albinism or congenital nystagmus
|
Uncertain significance (1) |
criteria provided, single submitter
|
Jul 1, 2024 | RCV004584139.1 |
click to load more click to collapse |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Oct 24, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000340022.4
First in ClinVar: Dec 06, 2016 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 23
Sex: mixed
|
|
Likely benign
(May 28, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Tyrosinase-negative oculocutaneous albinism
Affected status: unknown
Allele origin:
unknown
|
Mendelics
Accession: SCV001138404.1
First in ClinVar: Jan 09, 2020 Last updated: Jan 09, 2020 |
|
|
Uncertain significance
(Aug 19, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Tyrosinase-negative oculocutaneous albinism
Affected status: yes
Allele origin:
unknown
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Accession: SCV001370165.2
First in ClinVar: Jul 04, 2020 Last updated: Dec 12, 2020 |
Comment:
This variant was classified as: Uncertain significance. The available evidence favors the pathogenic nature of this variant, however the currently available data is insufficient to … (more)
This variant was classified as: Uncertain significance. The available evidence favors the pathogenic nature of this variant, however the currently available data is insufficient to conclusively support its pathogenic nature. Thus this variant is classified as Uncertain significance - favor pathogenic. The following ACMG criteria were applied in classifying this variant: PS3,PP3,PP4,PP5,BA1. This variant was detected in homozygous state. (less)
|
|
Uncertain significance
(Jul 22, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Tyrosinase-negative oculocutaneous albinism
Affected status: no
Allele origin:
germline
|
Genome-Nilou Lab
Accession: SCV001821910.1
First in ClinVar: Sep 08, 2021 Last updated: Sep 08, 2021 |
Sex: mixed
|
|
other
(May 24, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: no
Allele origin:
germline
|
Genetic Services Laboratory, University of Chicago
Accession: SCV000597779.3
First in ClinVar: Aug 28, 2017 Last updated: Jan 29, 2022 |
Comment:
DNA sequence analysis of the TYR gene demonstrated a sequence change, c.1205G>A, in exon 4 that results in an amino acid change, p.Arg402Gln. The p.Arg402Gln … (more)
DNA sequence analysis of the TYR gene demonstrated a sequence change, c.1205G>A, in exon 4 that results in an amino acid change, p.Arg402Gln. The p.Arg402Gln substitution is a well-documented temperature-sensitive reduced function allele that alone is not sufficient to cause an oculocutaneous albinism phenotype. However, the p.Arg402Gln substitution, if found in compound heterozygous state with a pathogenic mutation, may be associated with a mild oculocutaneous albinism type 1B (OCA1B) or ocular albinism (OA) phenotype (PMIDs: 7704033, 19938076, 18463683, 18326704, 23504663). The p.Arg402Gln substitution has been described in the gnomAD database with a high population frequency of 28% in the European American population (dbSNP rs1126809). Some studies have suggested that the p.Arg402Gln substitution is not associated with mild OCA1B or OA phenotype, due to its high frequency in the general population and the presence of this variant in trans with a pathogenic variant in unaffected parents (PMID: 19208379). It has been proposed that the p.Arg402Gln variant causes a partial albinism phenotype only when paired with certain genetic backgrounds (PMIDs: 7704033, 19938076) and multiple studies have shown that the p.Arg402Gln variant is more common in OCA patients with one TYR pathogenic variant than in patients with two pathogenic variants (PMIDs: 18463683, 18326704, 19938076, 23504663). (less)
|
|
Uncertain significance
(-)
|
criteria provided, single submitter
Method: clinical testing
|
NOT SPECIFIED
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV000303890.2
First in ClinVar: Oct 02, 2016 Last updated: Jan 06, 2024 |
Comment:
This variant is very common in the general population, being documented in 27% of alleles in individuals of European (Non-Finnish) descent. Given the high allele … (more)
This variant is very common in the general population, being documented in 27% of alleles in individuals of European (Non-Finnish) descent. Given the high allele frequency, including thousands of homozygotes this variant is not considered pathogenic individually. However, when this variant is in cis (present in the same copy of TYR) with the variant c.575C>A (p.Ser192Tyr), there is strong evidence that they create a pathogenic allele. Functional and phenotypic studies of the complex allele (p.[Arg402Gln;Ser192Tyr]; commonly referred to as a haplotype in the literature) indicate that the two substitutions have a compound effect on thermal stability of the protein and phenotypic spectrum of the individual (Tripathi et al. 1991. PubMed ID: 1820207; Chaki et al. 2011. PubMed ID: 20861851; Jagirdar et al. 2014. PubMed ID: 24739399). The p.[Arg402Gln;Ser192Tyr] allele is thought to be a recombination of the two individual variant alleles and is reported in ~1-2% of alleles (Jagirdar et al. 2014. PubMed ID: 24739399; Norman et al. 2017. PubMed ID: 28667292). However, this complex allele is enriched (up to 20%) in OCA patients with only one previously identified pathogenic variant in TYR (Lasseaux et al. 2018. PubMed ID: 29345414; Grønskov et al. 2019. PubMed ID: 30679655; Campbell et al. 2019. PubMed ID: 31719542). Given the evidence, we interpret the p.[Arg402Gln;Ser192Tyr] allele as likely pathogenic. When it is unclear whether the c.1205G>A (p.Arg402Gln) variant is part of the complex allele or not, then the clinical significance of it is uncertain. (less)
|
|
Benign
(Feb 01, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001731474.4
First in ClinVar: Jun 15, 2021 Last updated: Feb 20, 2024 |
|
|
Likely pathogenic
(-)
|
criteria provided, single submitter
Method: not provided
|
Oculocutaneous albinism type 1B
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Institute of Human Genetics, University Hospital of Duesseldorf
Accession: SCV005038701.1
First in ClinVar: May 07, 2024 Last updated: May 07, 2024 |
|
|
Uncertain significance
(Jul 01, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Albinism or congenital nystagmus
Affected status: yes
Allele origin:
germline
|
NHS Central & South Genomic Laboratory Hub
Accession: SCV005068233.1
First in ClinVar: Jul 07, 2024 Last updated: Jul 07, 2024 |
|
|
Likely benign
(Feb 08, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV003844442.1
First in ClinVar: Mar 26, 2023 Last updated: Mar 26, 2023 |
Comment:
Variant summary: TYR c.1205G>A (p.Arg402Gln) results in a conservative amino acid change located in the Tyrosinase copper-binding domain (IPR002227) of the encoded protein sequence. Four … (more)
Variant summary: TYR c.1205G>A (p.Arg402Gln) results in a conservative amino acid change located in the Tyrosinase copper-binding domain (IPR002227) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.18 in 250300 control chromosomes in the gnomAD database, including 5281 presumably unaffected homozygotes. The observed variant frequency is approximately 32 fold of the estimated maximal expected allele frequency for a pathogenic variant in TYR causing Oculocutaneous Albinism phenotype (0.0056), strongly suggesting that the variant is benign. Although widely reported in the literature due to its high population frequency, to our knowledge, no penetrant association of c.1205G>A in individuals affected with inherited autosomal recessive Oculocutaneous Albinism have been confirmed. There is evidence suggesting that c.1205G>A is acting as a hypomorphic variant, causing a mild form of albinism when in compound heterozygous state with a complete loss-of-function TYR change (example, Monferme_2019 cited in Michaud_2022). Homozygosity for a haplotype formed by three common, functionally-relevant variants, TYR c.[301C;575C>A;1205G>A], is associated with a high probability of receiving an albinism diagnosis (OR>82), although the 95% CI overlaps 1 (Michaud_2022). Per ACMG guidelines for the Interpretation of Sequence Variants, If the CI includes 1.0, there is little confidence in the assertion of association (Richards_2015). Ten clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments. Based on the evidence outlined above, the variant in isolation was classified as likely benign. (less)
|
|
Uncertain significance
(Oct 31, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Oculocutaneous albinism type 1
Affected status: unknown
Allele origin:
unknown
|
Illumina Laboratory Services, Illumina
Accession: SCV000374872.3
First in ClinVar: Dec 06, 2016 Last updated: Mar 23, 2024 |
Comment:
The TYR c.1205G>A p.(Arg402Gln) missense variant has been has been identified in individuals with a phenotype consistent oculocutaneous albinism (Monfermé et al. 2019; Chiang et … (more)
The TYR c.1205G>A p.(Arg402Gln) missense variant has been has been identified in individuals with a phenotype consistent oculocutaneous albinism (Monfermé et al. 2019; Chiang et al. 2009; Monferme et al. 2019). While this variant has been seen in affected individuals carrying two variants in TYR, it has also been seen in a compound heterozygous state in asymptomatic individuals (Chiang et al. 2009; Oetting et al. 2009; Monfermé et al. 2019). Furthermore, segregation studies have shown discrepant results, whereby some unaffected family members have the same genotype as affected individuals (Oetting et al. 2009). This variant has been reported at a frequency of 0.2728 in the European (non-Finnish) population of the Genome Aggregation Database (version 2.1.1) including many homozygotes. Despite the high frequency, this variant is suggested to be a hypomorphic allele with very reduced penetrance and highly variable expressivity, resulting in a milder form of oculocutaneous albinism (Chiang et al. 2009; Monfermé et al. 2019; Wang and Chiang 2019). It has also been suggested that additional modifiers may be playing a role in disease etiology (Wang and Chiang 2019). Functional studies have shown a temperature-sensitive effect of this variant in HeLa cells, whereby tyrosinase activity was reduced in cells that were transfected with p.(Arg402Gln variant plasmids compared to wild-type at 37 degrees Celsius, but not at 31 degrees Celsius. The authors suggest protein misfolding occurs in the presence of the variant (Tripathi et al. 1991). Similarly, experiments in cultured human melanocytes showed reduced enzyme activity and protein expression in homozygous variant melanocytes at 37 degrees Celsius. Protein expression was also decreased in skin samples. Immunofluorescence studies showed that variant protein was only localized in the endoplasmic reticulum, while wild-type was also present in dendrites, suggested occurrence of protein misfolding. Of note, melanin levels were not different between variant and wild-type melanocytes (Jagirdar et al. 2014). This variant is located near a copper binding domain and other missense variants observed in this region have been identified in patients (Oetting 2000). Based on the collective evidence, the c.1205G>A p.(Arg402Gln) variant is classified as a variant of uncertain significance for oculocutaneous albinism type 1. (less)
|
|
Pathogenic
(Jul 01, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV002821657.14
First in ClinVar: Jan 21, 2023 Last updated: Oct 20, 2024 |
Comment:
TYR: PM3:Very Strong, PM5, PM2:Supporting, BP4
Number of individuals with the variant: 53
|
|
association
(Jun 01, 2013)
|
no assertion criteria provided
Method: literature only
|
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000024147.5
First in ClinVar: Apr 04, 2013 Last updated: Feb 06, 2020 |
Comment on evidence:
Hutton and Spritz (2008) noted that the rs1126809 variant encodes a tyrosinase enzyme with an arg402-to-gln (R402Q) substitution, resulting in a tyrosinase peptide that is … (more)
Hutton and Spritz (2008) noted that the rs1126809 variant encodes a tyrosinase enzyme with an arg402-to-gln (R402Q) substitution, resulting in a tyrosinase peptide that is thermolabile and subject to endoplasmic reticulum retention, yielding only 25% of the catalytic activity of the wildtype enzyme at 37 degrees C. The SNP is quite common among Caucasians, with an allele frequency of approximately 0.278. Oetting et al. (2009) noted that the allele frequency is much lower in African Americans (0.05) and absent in the Asian population. Oculocutaneous Albinism Type IB Fukai et al. (1995) showed that a mild form of oculocutaneous albinism 1B (OCA1B; 606952) with only ocular albinism can result from compound heterozygosity for a mutant allele of TYR and the polymorphic R402Q allele. This polymorphic allele encodes a form of tyrosinase with reduced catalytic activity. Chiang et al. (2008) reported a Hispanic family in which 2 sibs had variable manifestations of OCA1B. A 6-year-old boy had nystagmus, decreased vision, light hair, light skin color, and foveal hypoplasia. His sister had exotropia, blonde hair, light skin color, and brown irides with no history of nystagmus, foveal hypoplasia or decreased vision. Genetic analysis identified compound heterozygosity for 2 variants in the TYR gene: G47D (606933.0024) and the hypomorphic allele R402Q. Each unaffected parent was heterozygous for 1 of the variants. Chiang et al. (2008) postulated that the clinical spectrum of OCA depends on a pigmentation threshold of the affected individual, and that OCA is a quantitative trait disorder with phenotypic variation in individuals of different ethnic backgrounds. In 36 unrelated Caucasian patients with a clinical diagnosis of autosomal recessive ocular albinism (AROA), Hutton and Spritz (2008) identified 20 patients who were compound heterozygous for the R402Q variant on 1 allele and for various severe OCA1 mutations on the other allele. The authors noted that this genotypic combination should occur in approximately 1 per 280 Caucasian individuals; however, the prevalence of AROA, while unknown, is certainly lower than that, indicating that the penetrance of the AROA phenotype must be very low, given a susceptible genotype. After excluding black and Asian OCA1 patients, Chiang et al. (2009) identified 23 OCA patients in their database with 1 or 2 TYR mutations. The authors found that 10 of the 11 patients with only 1 TYR mutation were heterozygous for the R402Q allele, whereas among the 12 patients with 2 mutations in TYR, 2 were heterozygous and 1 homozygous for R402Q, and 9 did not carry the R402Q allele. Chiang et al. (2009) concluded that the R402Q allele is strongly associated with albinism patients who have only 1 mutation in TYR. Oetting et al. (2009) analyzed the segregation of the Q402 allele in 12 families with oculocutaneous albinism type I in which all parents were unaffected with normal visual acuity. In 9 families, 1 parent in each sibship had a pathologic mutation on 1 allele and the Q402 allele in trans, yet none had hypopigmentation or the presence of abnormal visual acuity and fovial hypoplasia. In the remaining 3 families, 2 of which were previously studied by Hutton and Spritz (2008), the maternal mutation was not identified: in 1 family, the unaffected mother was homozygous for Q402 and also presumably carried an unidentified pathologic mutation; in another, the normal father had a pathologic mutation on 1 allele and Q402 in trans; and in the last family, the unaffected mother carried R402 on the allele presumably containing an unidentified mutation that was passed to her child, and Q402 in trans on the untransmitted allele. Oetting et al. (2009) concluded that the R402Q variant of TYR is not associated with autosomal recessive ocular albinism (AROA) but suggested that a causative variant may be in genetic disequilibrium with the R402Q variant. In 31 Caucasian patients with 1 or 2 mutations in the TYR gene, Simeonov et al. (2013) found that the R402Q allele was more frequent in the group with 1 mutation (50%) compared to the group with 2 mutations (10%). In 5 patients with no mutation in TYR who did not have paired trans-mutation in another OCA gene, they found that 40% of alleles had R402Q. Morell et al. (1997) found that the family reported by Bard (1978) with a combination of congenital deafness and ocular albinism had a syndrome apparently due to digenic inheritance. Affected individuals had features consistent with Waardenburg syndrome type 2 (WS2A; 193510) and ocular albinism; they were heterozygous for a 1-bp deletion in the MITF gene (156845.0005) and homozygous or heterozygous for the R402Q mutation. The transcription factor MITF regulates the expression of the TYR gene. Temperature-Sensitive Oculocutaneous Albinism In an unusual subset of oculocutaneous albinism type I, designated OCA1-TS (see 606952), mutations in the TYR gene render tyrosinase temperature-sensitive (ts). Consequently, melanin synthesis occurs only in cooler areas of the body, such as the arms and legs. The resultant pattern of peripheral pigmentation is analogous to that of the Siamese cat and the Himalayan mouse. Both the R402Q variant and the similar but less prevalent R422Q variant (606933.0012) are temperature-sensitive. The R402Q variant represents approximately 15% of the gene pool among Caucasians (King et al., 1991). Berson et al. (2000) analyzed the localization and processing of the R402Q variant and showed that the ts phenotype is due to a defect in protein folding that prevents exit from the endoplasmic reticulum (ER). The partial ts phenotype of a wildtype allelic form of tyrosinase and the lack of an apparent significant increase in ER-associated degradation of the R402Q variant suggested that it exaggerates an inefficient folding process inherent in human tyrosinase when expressed in nonmelanogenic cells. Variation in Skin/Hair/Eye Pigmentation In a genomewide association study using Icelandic and Dutch population samples, Sulem et al. (2007) found an association of the TYR SNP rs1042602 (S192Y; 606933.0008) with freckling (SHEP3; 601800). They also found strong correlation (r(2) = 0.86) of the TYR SNP rs1393350 with the TYR SNP rs1126809 (R402Q). Sulem et al. (2008) presented results from a genomewide association study for variants associated with human pigmentation characteristics among 5,130 Icelanders, with follow-up analyses in 2,116 Icelanders and 1,214 Dutch individuals. The rs1126809 R402Q variant showed genomewide significance for association with skin sensitivity to sun (p = 7.1 x 10(-13)) and blue versus green eye color (p = 4.6 x 10(-21)). Susceptibility to Cutaneous Malignant Melanoma In a study of the effect of pigmentation-associated genetic sequence variants on risk of cutaneous melanoma (see 601800) and basal cell carcinoma, Gudbjartsson et al. (2008) found that the R402Q variant of TYR, previously shown to affect eye color and tanning response, conferred risk of cutaneous melanoma (odds ratio = 1.21, p = 2.8 x 10(-7)) and basal cell carcinoma (odds ratio = 1.14, p = 6.1 x 10(-4)). (less)
|
|
association
(Jun 01, 2013)
|
no assertion criteria provided
Method: literature only
|
SKIN/HAIR/EYE PIGMENTATION 3, BLUE/GREEN EYES
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000024148.5
First in ClinVar: Apr 04, 2013 Last updated: Feb 06, 2020 |
Comment on evidence:
Hutton and Spritz (2008) noted that the rs1126809 variant encodes a tyrosinase enzyme with an arg402-to-gln (R402Q) substitution, resulting in a tyrosinase peptide that is … (more)
Hutton and Spritz (2008) noted that the rs1126809 variant encodes a tyrosinase enzyme with an arg402-to-gln (R402Q) substitution, resulting in a tyrosinase peptide that is thermolabile and subject to endoplasmic reticulum retention, yielding only 25% of the catalytic activity of the wildtype enzyme at 37 degrees C. The SNP is quite common among Caucasians, with an allele frequency of approximately 0.278. Oetting et al. (2009) noted that the allele frequency is much lower in African Americans (0.05) and absent in the Asian population. Oculocutaneous Albinism Type IB Fukai et al. (1995) showed that a mild form of oculocutaneous albinism 1B (OCA1B; 606952) with only ocular albinism can result from compound heterozygosity for a mutant allele of TYR and the polymorphic R402Q allele. This polymorphic allele encodes a form of tyrosinase with reduced catalytic activity. Chiang et al. (2008) reported a Hispanic family in which 2 sibs had variable manifestations of OCA1B. A 6-year-old boy had nystagmus, decreased vision, light hair, light skin color, and foveal hypoplasia. His sister had exotropia, blonde hair, light skin color, and brown irides with no history of nystagmus, foveal hypoplasia or decreased vision. Genetic analysis identified compound heterozygosity for 2 variants in the TYR gene: G47D (606933.0024) and the hypomorphic allele R402Q. Each unaffected parent was heterozygous for 1 of the variants. Chiang et al. (2008) postulated that the clinical spectrum of OCA depends on a pigmentation threshold of the affected individual, and that OCA is a quantitative trait disorder with phenotypic variation in individuals of different ethnic backgrounds. In 36 unrelated Caucasian patients with a clinical diagnosis of autosomal recessive ocular albinism (AROA), Hutton and Spritz (2008) identified 20 patients who were compound heterozygous for the R402Q variant on 1 allele and for various severe OCA1 mutations on the other allele. The authors noted that this genotypic combination should occur in approximately 1 per 280 Caucasian individuals; however, the prevalence of AROA, while unknown, is certainly lower than that, indicating that the penetrance of the AROA phenotype must be very low, given a susceptible genotype. After excluding black and Asian OCA1 patients, Chiang et al. (2009) identified 23 OCA patients in their database with 1 or 2 TYR mutations. The authors found that 10 of the 11 patients with only 1 TYR mutation were heterozygous for the R402Q allele, whereas among the 12 patients with 2 mutations in TYR, 2 were heterozygous and 1 homozygous for R402Q, and 9 did not carry the R402Q allele. Chiang et al. (2009) concluded that the R402Q allele is strongly associated with albinism patients who have only 1 mutation in TYR. Oetting et al. (2009) analyzed the segregation of the Q402 allele in 12 families with oculocutaneous albinism type I in which all parents were unaffected with normal visual acuity. In 9 families, 1 parent in each sibship had a pathologic mutation on 1 allele and the Q402 allele in trans, yet none had hypopigmentation or the presence of abnormal visual acuity and fovial hypoplasia. In the remaining 3 families, 2 of which were previously studied by Hutton and Spritz (2008), the maternal mutation was not identified: in 1 family, the unaffected mother was homozygous for Q402 and also presumably carried an unidentified pathologic mutation; in another, the normal father had a pathologic mutation on 1 allele and Q402 in trans; and in the last family, the unaffected mother carried R402 on the allele presumably containing an unidentified mutation that was passed to her child, and Q402 in trans on the untransmitted allele. Oetting et al. (2009) concluded that the R402Q variant of TYR is not associated with autosomal recessive ocular albinism (AROA) but suggested that a causative variant may be in genetic disequilibrium with the R402Q variant. In 31 Caucasian patients with 1 or 2 mutations in the TYR gene, Simeonov et al. (2013) found that the R402Q allele was more frequent in the group with 1 mutation (50%) compared to the group with 2 mutations (10%). In 5 patients with no mutation in TYR who did not have paired trans-mutation in another OCA gene, they found that 40% of alleles had R402Q. Morell et al. (1997) found that the family reported by Bard (1978) with a combination of congenital deafness and ocular albinism had a syndrome apparently due to digenic inheritance. Affected individuals had features consistent with Waardenburg syndrome type 2 (WS2A; 193510) and ocular albinism; they were heterozygous for a 1-bp deletion in the MITF gene (156845.0005) and homozygous or heterozygous for the R402Q mutation. The transcription factor MITF regulates the expression of the TYR gene. Temperature-Sensitive Oculocutaneous Albinism In an unusual subset of oculocutaneous albinism type I, designated OCA1-TS (see 606952), mutations in the TYR gene render tyrosinase temperature-sensitive (ts). Consequently, melanin synthesis occurs only in cooler areas of the body, such as the arms and legs. The resultant pattern of peripheral pigmentation is analogous to that of the Siamese cat and the Himalayan mouse. Both the R402Q variant and the similar but less prevalent R422Q variant (606933.0012) are temperature-sensitive. The R402Q variant represents approximately 15% of the gene pool among Caucasians (King et al., 1991). Berson et al. (2000) analyzed the localization and processing of the R402Q variant and showed that the ts phenotype is due to a defect in protein folding that prevents exit from the endoplasmic reticulum (ER). The partial ts phenotype of a wildtype allelic form of tyrosinase and the lack of an apparent significant increase in ER-associated degradation of the R402Q variant suggested that it exaggerates an inefficient folding process inherent in human tyrosinase when expressed in nonmelanogenic cells. Variation in Skin/Hair/Eye Pigmentation In a genomewide association study using Icelandic and Dutch population samples, Sulem et al. (2007) found an association of the TYR SNP rs1042602 (S192Y; 606933.0008) with freckling (SHEP3; 601800). They also found strong correlation (r(2) = 0.86) of the TYR SNP rs1393350 with the TYR SNP rs1126809 (R402Q). Sulem et al. (2008) presented results from a genomewide association study for variants associated with human pigmentation characteristics among 5,130 Icelanders, with follow-up analyses in 2,116 Icelanders and 1,214 Dutch individuals. The rs1126809 R402Q variant showed genomewide significance for association with skin sensitivity to sun (p = 7.1 x 10(-13)) and blue versus green eye color (p = 4.6 x 10(-21)). Susceptibility to Cutaneous Malignant Melanoma In a study of the effect of pigmentation-associated genetic sequence variants on risk of cutaneous melanoma (see 601800) and basal cell carcinoma, Gudbjartsson et al. (2008) found that the R402Q variant of TYR, previously shown to affect eye color and tanning response, conferred risk of cutaneous melanoma (odds ratio = 1.21, p = 2.8 x 10(-7)) and basal cell carcinoma (odds ratio = 1.14, p = 6.1 x 10(-4)). (less)
|
|
risk factor
(Jun 01, 2013)
|
no assertion criteria provided
Method: literature only
|
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000024146.5
First in ClinVar: Apr 04, 2013 Last updated: Feb 06, 2020 |
Comment on evidence:
Hutton and Spritz (2008) noted that the rs1126809 variant encodes a tyrosinase enzyme with an arg402-to-gln (R402Q) substitution, resulting in a tyrosinase peptide that is … (more)
Hutton and Spritz (2008) noted that the rs1126809 variant encodes a tyrosinase enzyme with an arg402-to-gln (R402Q) substitution, resulting in a tyrosinase peptide that is thermolabile and subject to endoplasmic reticulum retention, yielding only 25% of the catalytic activity of the wildtype enzyme at 37 degrees C. The SNP is quite common among Caucasians, with an allele frequency of approximately 0.278. Oetting et al. (2009) noted that the allele frequency is much lower in African Americans (0.05) and absent in the Asian population. Oculocutaneous Albinism Type IB Fukai et al. (1995) showed that a mild form of oculocutaneous albinism 1B (OCA1B; 606952) with only ocular albinism can result from compound heterozygosity for a mutant allele of TYR and the polymorphic R402Q allele. This polymorphic allele encodes a form of tyrosinase with reduced catalytic activity. Chiang et al. (2008) reported a Hispanic family in which 2 sibs had variable manifestations of OCA1B. A 6-year-old boy had nystagmus, decreased vision, light hair, light skin color, and foveal hypoplasia. His sister had exotropia, blonde hair, light skin color, and brown irides with no history of nystagmus, foveal hypoplasia or decreased vision. Genetic analysis identified compound heterozygosity for 2 variants in the TYR gene: G47D (606933.0024) and the hypomorphic allele R402Q. Each unaffected parent was heterozygous for 1 of the variants. Chiang et al. (2008) postulated that the clinical spectrum of OCA depends on a pigmentation threshold of the affected individual, and that OCA is a quantitative trait disorder with phenotypic variation in individuals of different ethnic backgrounds. In 36 unrelated Caucasian patients with a clinical diagnosis of autosomal recessive ocular albinism (AROA), Hutton and Spritz (2008) identified 20 patients who were compound heterozygous for the R402Q variant on 1 allele and for various severe OCA1 mutations on the other allele. The authors noted that this genotypic combination should occur in approximately 1 per 280 Caucasian individuals; however, the prevalence of AROA, while unknown, is certainly lower than that, indicating that the penetrance of the AROA phenotype must be very low, given a susceptible genotype. After excluding black and Asian OCA1 patients, Chiang et al. (2009) identified 23 OCA patients in their database with 1 or 2 TYR mutations. The authors found that 10 of the 11 patients with only 1 TYR mutation were heterozygous for the R402Q allele, whereas among the 12 patients with 2 mutations in TYR, 2 were heterozygous and 1 homozygous for R402Q, and 9 did not carry the R402Q allele. Chiang et al. (2009) concluded that the R402Q allele is strongly associated with albinism patients who have only 1 mutation in TYR. Oetting et al. (2009) analyzed the segregation of the Q402 allele in 12 families with oculocutaneous albinism type I in which all parents were unaffected with normal visual acuity. In 9 families, 1 parent in each sibship had a pathologic mutation on 1 allele and the Q402 allele in trans, yet none had hypopigmentation or the presence of abnormal visual acuity and fovial hypoplasia. In the remaining 3 families, 2 of which were previously studied by Hutton and Spritz (2008), the maternal mutation was not identified: in 1 family, the unaffected mother was homozygous for Q402 and also presumably carried an unidentified pathologic mutation; in another, the normal father had a pathologic mutation on 1 allele and Q402 in trans; and in the last family, the unaffected mother carried R402 on the allele presumably containing an unidentified mutation that was passed to her child, and Q402 in trans on the untransmitted allele. Oetting et al. (2009) concluded that the R402Q variant of TYR is not associated with autosomal recessive ocular albinism (AROA) but suggested that a causative variant may be in genetic disequilibrium with the R402Q variant. In 31 Caucasian patients with 1 or 2 mutations in the TYR gene, Simeonov et al. (2013) found that the R402Q allele was more frequent in the group with 1 mutation (50%) compared to the group with 2 mutations (10%). In 5 patients with no mutation in TYR who did not have paired trans-mutation in another OCA gene, they found that 40% of alleles had R402Q. Morell et al. (1997) found that the family reported by Bard (1978) with a combination of congenital deafness and ocular albinism had a syndrome apparently due to digenic inheritance. Affected individuals had features consistent with Waardenburg syndrome type 2 (WS2A; 193510) and ocular albinism; they were heterozygous for a 1-bp deletion in the MITF gene (156845.0005) and homozygous or heterozygous for the R402Q mutation. The transcription factor MITF regulates the expression of the TYR gene. Temperature-Sensitive Oculocutaneous Albinism In an unusual subset of oculocutaneous albinism type I, designated OCA1-TS (see 606952), mutations in the TYR gene render tyrosinase temperature-sensitive (ts). Consequently, melanin synthesis occurs only in cooler areas of the body, such as the arms and legs. The resultant pattern of peripheral pigmentation is analogous to that of the Siamese cat and the Himalayan mouse. Both the R402Q variant and the similar but less prevalent R422Q variant (606933.0012) are temperature-sensitive. The R402Q variant represents approximately 15% of the gene pool among Caucasians (King et al., 1991). Berson et al. (2000) analyzed the localization and processing of the R402Q variant and showed that the ts phenotype is due to a defect in protein folding that prevents exit from the endoplasmic reticulum (ER). The partial ts phenotype of a wildtype allelic form of tyrosinase and the lack of an apparent significant increase in ER-associated degradation of the R402Q variant suggested that it exaggerates an inefficient folding process inherent in human tyrosinase when expressed in nonmelanogenic cells. Variation in Skin/Hair/Eye Pigmentation In a genomewide association study using Icelandic and Dutch population samples, Sulem et al. (2007) found an association of the TYR SNP rs1042602 (S192Y; 606933.0008) with freckling (SHEP3; 601800). They also found strong correlation (r(2) = 0.86) of the TYR SNP rs1393350 with the TYR SNP rs1126809 (R402Q). Sulem et al. (2008) presented results from a genomewide association study for variants associated with human pigmentation characteristics among 5,130 Icelanders, with follow-up analyses in 2,116 Icelanders and 1,214 Dutch individuals. The rs1126809 R402Q variant showed genomewide significance for association with skin sensitivity to sun (p = 7.1 x 10(-13)) and blue versus green eye color (p = 4.6 x 10(-21)). Susceptibility to Cutaneous Malignant Melanoma In a study of the effect of pigmentation-associated genetic sequence variants on risk of cutaneous melanoma (see 601800) and basal cell carcinoma, Gudbjartsson et al. (2008) found that the R402Q variant of TYR, previously shown to affect eye color and tanning response, conferred risk of cutaneous melanoma (odds ratio = 1.21, p = 2.8 x 10(-7)) and basal cell carcinoma (odds ratio = 1.14, p = 6.1 x 10(-4)). (less)
|
|
Pathogenic
(Jun 01, 2013)
|
no assertion criteria provided
Method: literature only
|
ALBINISM, OCULOCUTANEOUS, TYPE IB
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000024143.5
First in ClinVar: Apr 04, 2013 Last updated: Feb 06, 2020 |
Comment on evidence:
Hutton and Spritz (2008) noted that the rs1126809 variant encodes a tyrosinase enzyme with an arg402-to-gln (R402Q) substitution, resulting in a tyrosinase peptide that is … (more)
Hutton and Spritz (2008) noted that the rs1126809 variant encodes a tyrosinase enzyme with an arg402-to-gln (R402Q) substitution, resulting in a tyrosinase peptide that is thermolabile and subject to endoplasmic reticulum retention, yielding only 25% of the catalytic activity of the wildtype enzyme at 37 degrees C. The SNP is quite common among Caucasians, with an allele frequency of approximately 0.278. Oetting et al. (2009) noted that the allele frequency is much lower in African Americans (0.05) and absent in the Asian population. Oculocutaneous Albinism Type IB Fukai et al. (1995) showed that a mild form of oculocutaneous albinism 1B (OCA1B; 606952) with only ocular albinism can result from compound heterozygosity for a mutant allele of TYR and the polymorphic R402Q allele. This polymorphic allele encodes a form of tyrosinase with reduced catalytic activity. Chiang et al. (2008) reported a Hispanic family in which 2 sibs had variable manifestations of OCA1B. A 6-year-old boy had nystagmus, decreased vision, light hair, light skin color, and foveal hypoplasia. His sister had exotropia, blonde hair, light skin color, and brown irides with no history of nystagmus, foveal hypoplasia or decreased vision. Genetic analysis identified compound heterozygosity for 2 variants in the TYR gene: G47D (606933.0024) and the hypomorphic allele R402Q. Each unaffected parent was heterozygous for 1 of the variants. Chiang et al. (2008) postulated that the clinical spectrum of OCA depends on a pigmentation threshold of the affected individual, and that OCA is a quantitative trait disorder with phenotypic variation in individuals of different ethnic backgrounds. In 36 unrelated Caucasian patients with a clinical diagnosis of autosomal recessive ocular albinism (AROA), Hutton and Spritz (2008) identified 20 patients who were compound heterozygous for the R402Q variant on 1 allele and for various severe OCA1 mutations on the other allele. The authors noted that this genotypic combination should occur in approximately 1 per 280 Caucasian individuals; however, the prevalence of AROA, while unknown, is certainly lower than that, indicating that the penetrance of the AROA phenotype must be very low, given a susceptible genotype. After excluding black and Asian OCA1 patients, Chiang et al. (2009) identified 23 OCA patients in their database with 1 or 2 TYR mutations. The authors found that 10 of the 11 patients with only 1 TYR mutation were heterozygous for the R402Q allele, whereas among the 12 patients with 2 mutations in TYR, 2 were heterozygous and 1 homozygous for R402Q, and 9 did not carry the R402Q allele. Chiang et al. (2009) concluded that the R402Q allele is strongly associated with albinism patients who have only 1 mutation in TYR. Oetting et al. (2009) analyzed the segregation of the Q402 allele in 12 families with oculocutaneous albinism type I in which all parents were unaffected with normal visual acuity. In 9 families, 1 parent in each sibship had a pathologic mutation on 1 allele and the Q402 allele in trans, yet none had hypopigmentation or the presence of abnormal visual acuity and fovial hypoplasia. In the remaining 3 families, 2 of which were previously studied by Hutton and Spritz (2008), the maternal mutation was not identified: in 1 family, the unaffected mother was homozygous for Q402 and also presumably carried an unidentified pathologic mutation; in another, the normal father had a pathologic mutation on 1 allele and Q402 in trans; and in the last family, the unaffected mother carried R402 on the allele presumably containing an unidentified mutation that was passed to her child, and Q402 in trans on the untransmitted allele. Oetting et al. (2009) concluded that the R402Q variant of TYR is not associated with autosomal recessive ocular albinism (AROA) but suggested that a causative variant may be in genetic disequilibrium with the R402Q variant. In 31 Caucasian patients with 1 or 2 mutations in the TYR gene, Simeonov et al. (2013) found that the R402Q allele was more frequent in the group with 1 mutation (50%) compared to the group with 2 mutations (10%). In 5 patients with no mutation in TYR who did not have paired trans-mutation in another OCA gene, they found that 40% of alleles had R402Q. Morell et al. (1997) found that the family reported by Bard (1978) with a combination of congenital deafness and ocular albinism had a syndrome apparently due to digenic inheritance. Affected individuals had features consistent with Waardenburg syndrome type 2 (WS2A; 193510) and ocular albinism; they were heterozygous for a 1-bp deletion in the MITF gene (156845.0005) and homozygous or heterozygous for the R402Q mutation. The transcription factor MITF regulates the expression of the TYR gene. Temperature-Sensitive Oculocutaneous Albinism In an unusual subset of oculocutaneous albinism type I, designated OCA1-TS (see 606952), mutations in the TYR gene render tyrosinase temperature-sensitive (ts). Consequently, melanin synthesis occurs only in cooler areas of the body, such as the arms and legs. The resultant pattern of peripheral pigmentation is analogous to that of the Siamese cat and the Himalayan mouse. Both the R402Q variant and the similar but less prevalent R422Q variant (606933.0012) are temperature-sensitive. The R402Q variant represents approximately 15% of the gene pool among Caucasians (King et al., 1991). Berson et al. (2000) analyzed the localization and processing of the R402Q variant and showed that the ts phenotype is due to a defect in protein folding that prevents exit from the endoplasmic reticulum (ER). The partial ts phenotype of a wildtype allelic form of tyrosinase and the lack of an apparent significant increase in ER-associated degradation of the R402Q variant suggested that it exaggerates an inefficient folding process inherent in human tyrosinase when expressed in nonmelanogenic cells. Variation in Skin/Hair/Eye Pigmentation In a genomewide association study using Icelandic and Dutch population samples, Sulem et al. (2007) found an association of the TYR SNP rs1042602 (S192Y; 606933.0008) with freckling (SHEP3; 601800). They also found strong correlation (r(2) = 0.86) of the TYR SNP rs1393350 with the TYR SNP rs1126809 (R402Q). Sulem et al. (2008) presented results from a genomewide association study for variants associated with human pigmentation characteristics among 5,130 Icelanders, with follow-up analyses in 2,116 Icelanders and 1,214 Dutch individuals. The rs1126809 R402Q variant showed genomewide significance for association with skin sensitivity to sun (p = 7.1 x 10(-13)) and blue versus green eye color (p = 4.6 x 10(-21)). Susceptibility to Cutaneous Malignant Melanoma In a study of the effect of pigmentation-associated genetic sequence variants on risk of cutaneous melanoma (see 601800) and basal cell carcinoma, Gudbjartsson et al. (2008) found that the R402Q variant of TYR, previously shown to affect eye color and tanning response, conferred risk of cutaneous melanoma (odds ratio = 1.21, p = 2.8 x 10(-7)) and basal cell carcinoma (odds ratio = 1.14, p = 6.1 x 10(-4)). (less)
|
|
Pathogenic
(Jun 01, 2013)
|
no assertion criteria provided
Method: literature only
|
ALBINISM, OCULOCUTANEOUS TYPE I, TEMPERATURE-SENSITIVE
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000024145.5
First in ClinVar: Apr 04, 2013 Last updated: Feb 06, 2020 |
Comment on evidence:
Hutton and Spritz (2008) noted that the rs1126809 variant encodes a tyrosinase enzyme with an arg402-to-gln (R402Q) substitution, resulting in a tyrosinase peptide that is … (more)
Hutton and Spritz (2008) noted that the rs1126809 variant encodes a tyrosinase enzyme with an arg402-to-gln (R402Q) substitution, resulting in a tyrosinase peptide that is thermolabile and subject to endoplasmic reticulum retention, yielding only 25% of the catalytic activity of the wildtype enzyme at 37 degrees C. The SNP is quite common among Caucasians, with an allele frequency of approximately 0.278. Oetting et al. (2009) noted that the allele frequency is much lower in African Americans (0.05) and absent in the Asian population. Oculocutaneous Albinism Type IB Fukai et al. (1995) showed that a mild form of oculocutaneous albinism 1B (OCA1B; 606952) with only ocular albinism can result from compound heterozygosity for a mutant allele of TYR and the polymorphic R402Q allele. This polymorphic allele encodes a form of tyrosinase with reduced catalytic activity. Chiang et al. (2008) reported a Hispanic family in which 2 sibs had variable manifestations of OCA1B. A 6-year-old boy had nystagmus, decreased vision, light hair, light skin color, and foveal hypoplasia. His sister had exotropia, blonde hair, light skin color, and brown irides with no history of nystagmus, foveal hypoplasia or decreased vision. Genetic analysis identified compound heterozygosity for 2 variants in the TYR gene: G47D (606933.0024) and the hypomorphic allele R402Q. Each unaffected parent was heterozygous for 1 of the variants. Chiang et al. (2008) postulated that the clinical spectrum of OCA depends on a pigmentation threshold of the affected individual, and that OCA is a quantitative trait disorder with phenotypic variation in individuals of different ethnic backgrounds. In 36 unrelated Caucasian patients with a clinical diagnosis of autosomal recessive ocular albinism (AROA), Hutton and Spritz (2008) identified 20 patients who were compound heterozygous for the R402Q variant on 1 allele and for various severe OCA1 mutations on the other allele. The authors noted that this genotypic combination should occur in approximately 1 per 280 Caucasian individuals; however, the prevalence of AROA, while unknown, is certainly lower than that, indicating that the penetrance of the AROA phenotype must be very low, given a susceptible genotype. After excluding black and Asian OCA1 patients, Chiang et al. (2009) identified 23 OCA patients in their database with 1 or 2 TYR mutations. The authors found that 10 of the 11 patients with only 1 TYR mutation were heterozygous for the R402Q allele, whereas among the 12 patients with 2 mutations in TYR, 2 were heterozygous and 1 homozygous for R402Q, and 9 did not carry the R402Q allele. Chiang et al. (2009) concluded that the R402Q allele is strongly associated with albinism patients who have only 1 mutation in TYR. Oetting et al. (2009) analyzed the segregation of the Q402 allele in 12 families with oculocutaneous albinism type I in which all parents were unaffected with normal visual acuity. In 9 families, 1 parent in each sibship had a pathologic mutation on 1 allele and the Q402 allele in trans, yet none had hypopigmentation or the presence of abnormal visual acuity and fovial hypoplasia. In the remaining 3 families, 2 of which were previously studied by Hutton and Spritz (2008), the maternal mutation was not identified: in 1 family, the unaffected mother was homozygous for Q402 and also presumably carried an unidentified pathologic mutation; in another, the normal father had a pathologic mutation on 1 allele and Q402 in trans; and in the last family, the unaffected mother carried R402 on the allele presumably containing an unidentified mutation that was passed to her child, and Q402 in trans on the untransmitted allele. Oetting et al. (2009) concluded that the R402Q variant of TYR is not associated with autosomal recessive ocular albinism (AROA) but suggested that a causative variant may be in genetic disequilibrium with the R402Q variant. In 31 Caucasian patients with 1 or 2 mutations in the TYR gene, Simeonov et al. (2013) found that the R402Q allele was more frequent in the group with 1 mutation (50%) compared to the group with 2 mutations (10%). In 5 patients with no mutation in TYR who did not have paired trans-mutation in another OCA gene, they found that 40% of alleles had R402Q. Morell et al. (1997) found that the family reported by Bard (1978) with a combination of congenital deafness and ocular albinism had a syndrome apparently due to digenic inheritance. Affected individuals had features consistent with Waardenburg syndrome type 2 (WS2A; 193510) and ocular albinism; they were heterozygous for a 1-bp deletion in the MITF gene (156845.0005) and homozygous or heterozygous for the R402Q mutation. The transcription factor MITF regulates the expression of the TYR gene. Temperature-Sensitive Oculocutaneous Albinism In an unusual subset of oculocutaneous albinism type I, designated OCA1-TS (see 606952), mutations in the TYR gene render tyrosinase temperature-sensitive (ts). Consequently, melanin synthesis occurs only in cooler areas of the body, such as the arms and legs. The resultant pattern of peripheral pigmentation is analogous to that of the Siamese cat and the Himalayan mouse. Both the R402Q variant and the similar but less prevalent R422Q variant (606933.0012) are temperature-sensitive. The R402Q variant represents approximately 15% of the gene pool among Caucasians (King et al., 1991). Berson et al. (2000) analyzed the localization and processing of the R402Q variant and showed that the ts phenotype is due to a defect in protein folding that prevents exit from the endoplasmic reticulum (ER). The partial ts phenotype of a wildtype allelic form of tyrosinase and the lack of an apparent significant increase in ER-associated degradation of the R402Q variant suggested that it exaggerates an inefficient folding process inherent in human tyrosinase when expressed in nonmelanogenic cells. Variation in Skin/Hair/Eye Pigmentation In a genomewide association study using Icelandic and Dutch population samples, Sulem et al. (2007) found an association of the TYR SNP rs1042602 (S192Y; 606933.0008) with freckling (SHEP3; 601800). They also found strong correlation (r(2) = 0.86) of the TYR SNP rs1393350 with the TYR SNP rs1126809 (R402Q). Sulem et al. (2008) presented results from a genomewide association study for variants associated with human pigmentation characteristics among 5,130 Icelanders, with follow-up analyses in 2,116 Icelanders and 1,214 Dutch individuals. The rs1126809 R402Q variant showed genomewide significance for association with skin sensitivity to sun (p = 7.1 x 10(-13)) and blue versus green eye color (p = 4.6 x 10(-21)). Susceptibility to Cutaneous Malignant Melanoma In a study of the effect of pigmentation-associated genetic sequence variants on risk of cutaneous melanoma (see 601800) and basal cell carcinoma, Gudbjartsson et al. (2008) found that the R402Q variant of TYR, previously shown to affect eye color and tanning response, conferred risk of cutaneous melanoma (odds ratio = 1.21, p = 2.8 x 10(-7)) and basal cell carcinoma (odds ratio = 1.14, p = 6.1 x 10(-4)). (less)
|
|
Likely benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
Breast Cancer
Affected status: yes
Allele origin:
germline
|
Center of Medical Genetics and Primary Health Care
Accession: SCV001448732.1
First in ClinVar: Dec 07, 2020 Last updated: Dec 07, 2020 |
|
|
other
(Sep 10, 2018)
|
no assertion criteria provided
Method: clinical testing
|
Autosomal recessive ocular albinism
Affected status: yes
Allele origin:
germline
|
Molecular Vision Laboratory
Accession: SCV000852087.1
First in ClinVar: Nov 17, 2018 Last updated: Nov 17, 2018 |
Comment:
Autosomal recessive ocular albinism (AROA) has been linked to compound heterozygosity of TYR mutations with Arg402Gln. Arg402Gln has been shown to encode for a tyrosinase … (more)
Autosomal recessive ocular albinism (AROA) has been linked to compound heterozygosity of TYR mutations with Arg402Gln. Arg402Gln has been shown to encode for a tyrosinase with reduced thermal stability suggesting a hypomorphic effect. The variant has reduced penetrance as there exists a discrepancy between expected incidence of Arg402Gln compound heterozygotes and AROA prevalence. Segregation studies have also revealed unaffected compound heterozygotes suggesting there are additional factors contributing to the AROA condition. Population allele frequency is high (gnomAD AF 0.19287) and there are unaffected homozygotes. (less)
|
|
Benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
Tyrosinase-negative oculocutaneous albinism
Affected status: yes
Allele origin:
unknown
|
Department of Pathology and Laboratory Medicine, Sinai Health System
Additional submitter:
Franklin by Genoox
Study: The Canadian Open Genetics Repository (COGR)
Accession: SCV001551479.1 First in ClinVar: Apr 13, 2021 Last updated: Apr 13, 2021 |
Comment:
The variant TYR:c.1205G>A (p.Arg402Gln) was identified in dbSNP (ID: rs1126809) and ClinVar. The variant was identified in ClinVar with conflicting classifications (classified as pathogenic by … (more)
The variant TYR:c.1205G>A (p.Arg402Gln) was identified in dbSNP (ID: rs1126809) and ClinVar. The variant was identified in ClinVar with conflicting classifications (classified as pathogenic by OMIM, classified as likely pathogenic by the Centre for Mendelian Genomics, classified as uncertain significance by EGL Genetic Diagnostics, classified as likely benign by Illumina Clinical Services Laboratory, classified as benign by GeneReviews and PreventionGenetics). In one study, 122 patients had one pathogenic variant of the TYR gene and the p.Arg402Gln variant within a cohort of 268 patients diagnosed with oculocutaneous albinism type 1 (OCA1), emphasizing in favour of p.Arg402Gln being a mildly pathogenic TYR variant when associated in trans with another pathogenic variant (Monferme_2018_30472657). In another study, 2 patients in a cohort of 12 presenting with autosomal recessive ocular albinism (AROA) were each a compound heterozygote for a different pathologic mutant allele and an allele containing a ‘normal’ polymorphism, Arg402Gln. In these patients, AROA thus appears to represent a clinically mild form of OCA1 (Fukai_1995_7704033). Another study involving the clinical diagnosis of 30 Iranian OCA1 patients detected 6 patients with the heterozygous p.Arg402Gln variant, with two of those patients heterozygous for one other reported missense mutation in the TYR gene (Kalahroudi_2014_ 25216246). In another cohort with 18 probands categorized as having hypomorphic albinism, 6 had inherited the p.Arg402Gln variant in addition to another common TYR variant, p.Ser192Tyr (Norman_2017_28667292). The variant was identified in control databases in 49,703 of 281,606 chromosomes (5,932 homozygous) at a frequency of 17.6498%, and was observed at the highest frequency in the European-Non Finnish (NFE) population in 3501 of 128,366 chromosomes (freq: 4,795) (Genome Aggregation Database March 6, 2019, v2.1.1). The p.Arg402Gln residue is conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a deleterious effect on splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. (less)
|
|
not provided
(-)
|
no classification provided
Method: not provided
|
not provided
Affected status: not provided
Allele origin:
unknown
|
Retina International
Accession: SCV000118053.1
First in ClinVar: Feb 20, 2014 Last updated: Feb 20, 2014
Comment:
http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg19&id=RISN_TYR:c.1205G>A
|
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Oculocutaneous albinism type 1B
Affected status: not provided
Allele origin:
unknown
|
GeneReviews
Accession: SCV000086776.2
First in ClinVar: Oct 01, 2013 Last updated: Oct 01, 2022 |
|
|
Likely pathogenic
(Jan 01, 2017)
|
Flagged submission
flagged submission
Method: clinical testing
Reason: Older claim that does not account for recent evidence
Source: ClinGen
|
Abnormality of metabolism/homeostasis
Albinism Choroidal neovascularization Elevated circulating hepatic transaminase concentration Foveal hypoplasia Slow decrease in visual acuity
Affected status: yes
Allele origin:
unknown
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Accession: SCV000747376.1
First in ClinVar: May 12, 2018 Last updated: May 12, 2018 |
|
|
click to load more click to collapse | |||||
Flagged submissions do not contribute to the aggregate classification or review status for the variant. Learn more |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism. | Michaud V | Nature communications | 2022 | PMID: 35803923 |
Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the TYR gene. | Monfermé S | The British journal of ophthalmology | 2019 | PMID: 30472657 |
Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1). | Ghodsinejad Kalahroudi V | PloS one | 2014 | PMID: 25216246 |
DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics. | Simeonov DR | Human mutation | 2013 | PMID: 23504663 |
Oculocutaneous Albinism Type 1 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. | Adam MP | - | 2013 | PMID: 20301345 |
Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism. | Preising MN | Molecular vision | 2011 | PMID: 21541274 |
Oculocutaneous albinism spectrum. | Chiang PW | American journal of medical genetics. Part A | 2009 | PMID: 19533789 |
The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism. | Oetting WS | American journal of medical genetics. Part A | 2009 | PMID: 19208379 |
A new hypothesis of OCA1B. | Chiang PW | American journal of medical genetics. Part A | 2008 | PMID: 18925668 |
Two newly identified genetic determinants of pigmentation in Europeans. | Sulem P | Nature genetics | 2008 | PMID: 18488028 |
ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. | Gudbjartsson DF | Nature genetics | 2008 | PMID: 18488027 |
A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients. | Hutton SM | Investigative ophthalmology & visual science | 2008 | PMID: 18326704 |
Genetic determinants of hair, eye and skin pigmentation in Europeans. | Sulem P | Nature genetics | 2007 | PMID: 17952075 |
A common temperature-sensitive allelic form of human tyrosinase is retained in the endoplasmic reticulum at the nonpermissive temperature. | Berson JF | The Journal of biological chemistry | 2000 | PMID: 10766867 |
Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA). | Morell R | Human molecular genetics | 1997 | PMID: 9158138 |
Autosomal recessive ocular albinism associated with a functionally significant tyrosinase gene polymorphism. | Fukai K | Nature genetics | 1995 | PMID: 7704033 |
Mutational mapping of the catalytic activities of human tyrosinase. | Tripathi RK | The Journal of biological chemistry | 1992 | PMID: 1429711 |
A polymorphism of the human tyrosinase gene is associated with temperature-sensitive enzymatic activity. | Tripathi RK | Gene expression | 1991 | PMID: 1820207 |
Heterogeneity in Waardenburg's syndrome. Report of a family with ocular albinism. | Bard LA | Archives of ophthalmology (Chicago, Ill. : 1960) | 1978 | PMID: 666627 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=TYR | - | - | - | - |
King, R. A., Townsend, D., Oetting, W. S., Spritz, R. A. An unusual pigment pattern in type I oculocutaneous albinism (OCA) resulting from a temperature-sensitive enzyme. (Abstract) Am. J. Hum. Genet. 45 (suppl.): A8, 1989. | - | - | - | - |
click to load more click to collapse |
Text-mined citations for rs1126809 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.